Public, NASDAQ:ZIOP
NASDAQ Capital Market
Ziopharm Oncology Says FDA Accepts IND For Oral Palifosfamide - Quick Facts
Date: Mon, 06 Feb 2012 11:30:13 GMT
Tags:
Ziopharm Oncology Says FDA Accepts IND For Oral Palifosfamide - Quick Facts
NASDAQ - Feb 6, 2012
NASDAQ - Feb 6, 2012
(RTTNews.com) - Ziopharm Oncology Inc. (ZIOP) announced that the US Food and Drug Administration has accepted its investigational new drug or IND application for the oral dosing of palifosfamide or Zymafos or ZIO-201.
Ziopharm Oncology Says FDA Accepts IND For Oral Palifosfamide - Quick Facts
Date: Mon, 06 Feb 2012 11:24:53 GMT
Tags:
Ziopharm Oncology Says FDA Accepts IND For Oral Palifosfamide - Quick Facts
RTT News - Feb 6, 2012
RTT News - Feb 6, 2012
(RTTNews) - Ziopharm Oncology Inc. (ZIOP: News ) announced that the US Food and Drug Administration has accepted its investigational new drug or IND application for the oral dosing of palifosfamide or Zymafos or ZIO-201.
ZIOPHARM Announces FDA Acceptance of IND for Oral Palifosfamide - MarketWatch (press release)ZIOPHARM Oncology Inc. Announces FDA Acceptance Of IND For Oral Palifosfamide
Date: Mon, 06 Feb 2012 11:10:00 GMT
Tags:
ZIOPHARM Oncology Inc. Announces FDA Acceptance Of IND For Oral Palifosfamide
Reuters Key Development - Feb 6, 2012
Reuters Key Development - Feb 6, 2012
14 Rallying Biotech Stocks Being Snapped Up By Insiders
Date: Thu, 02 Feb 2012 06:17:14 GMT
Tags:
14 Rallying Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha - Feb 2, 2012
Seeking Alpha - Feb 2, 2012
Want to know the inside scoop? One of the best sources for what company insiders actually think about their companies is trends in insider buying.
ZIOPHARM Says IDMC Recommends To Continue Phase 3 Study Of Palifosfamide
Date: Mon, 30 Jan 2012 11:29:19 GMT
Tags:
ZIOPHARM Says IDMC Recommends To Continue Phase 3 Study Of Palifosfamide
RTT News - Jan 30, 2012
RTT News - Jan 30, 2012
(RTTNews) - ZIOPHARM Oncology Inc. (ZIOP: News ) announced that the Independent Data Monitoring Committee or IDMC has unanimously recommended continuation of the international, randomized, double-blinded, placebo-controlled Phase 3 trial or PICASSO 3 ...
ZIOPHARM Oncology Announces Recommendation by Independent Data Monitoring ... - PipelineReview.com (press release)ZIOPHARM Oncology to Present at the 14th Annual BIO CEO & Investor Conference
Date: Tue, 07 Feb 2012 11:10:00 GMT
Tags:
[GlobeNewswire] - NEW YORK -- ZIOPHARM Oncology, Inc. announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 ...
InPlay: Ziopharm Oncology: FDA accepts investigational new drug application for oral palifosfamide
Date: Mon, 06 Feb 2012 11:11:41 GMT
Tags:
ZIOPHARM Announces FDA Acceptance of IND for Oral Palifosfamide
Date: Mon, 06 Feb 2012 11:10:00 GMT
Tags:
[GlobeNewswire] - NEW YORK -- ZIOPHARM Oncology, Inc. , a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer therapies, announced today that the U.S. Food and Drug Administration ...
UPDATE 1-Ziopharm to continue cancer drug trial
Date: Mon, 30 Jan 2012 12:05:06 GMT
Tags:
ZIOPHARM Oncology Announces Recommendation by Independent Data Monitoring Committee to Continue Phase 3 Study of Palifosfamide in Metastatic Soft Tissue Sarcoma
Date: Mon, 30 Jan 2012 11:10:00 GMT
Tags:
[GlobeNewswire] - NEW YORK -- ZIOPHARM Oncology, Inc. , a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer therapies, announced today that the Independent Data Monitoring Committee ...